Submitted September 16, 2009, and accepted on November 20, 2009 for presentation at the 54th Annual Meeting of the Biophysical Society, February 24, 2010 in San Francisco, California.
   Prorgam Number: 3843-Pos,    Poster Board Number: B567.
Biophysical J., vol.98, issue 3, supplement 1, pages 1-766, (January, 2010).
http://www.sciencedirect.com/science?_ob=PublicationURL&_tockey=


"Cellular Dynamics of Embryomas within Adult Neoplasms".

John H. Frenster 1 and Jeannette A. Hovsepian 2
Divisions of 1 Medical Oncology and 2 Diagnostic Radiology
Stanford University School of Medicine
Stanford CA 94027-5446

Supported in part by a USPHS Research Career Development Award CA-17857
from the National Cancer Insitute.

e-mail:  frensasc@ ix.netcom.com        phone: 650/367-6483
http://www.cancerbiophysics.net/



Abstract:

During vertebrate life, a single cell will contain a single genome until cell death.
This genome contains some genes for embryonic development, some genes
for adult expression, and other genes which are used  both in embryonic
life and in adult life. Embryonic-exclusive genes are exquistively selected
for complicated expression during organ formation before birth, and are
under close supervision  by embryonic regulator proteins and RNAs. After
birth, the embryonic-exclusive genes are no longer needed, but they are
retained in the inactive form within the cell until cell death. The embryonic
regulator proteins and RNAs are then replaced by adult regulator proteins and RNAs.
Thus, within the adult cell, the inactive embryonic-exclusive genes are left without
embryonic regulator proteins and RNAs. In this open state, such embryonic
-exclusive genes may again become active. The activation of as little as one
embryo-exclusive gene within an adult cell is capable of initiating a new
neoplasm within that cell. Such neoplasms are termed embryomas, and
as they divide and recruit other embryonic genes to regain similar activity,  the
new neoplasm will progress to kill the host animal. The dynamics of such embryoma
activation  and progression is often as explosive,  cumulative, and destructive
as an avalanche in character. Recently it has been found that  providing the
missing embryonic regulatory micro RNAs, either in vitro or in vivo,  will
reduce the activity of such embryomas, without apparent toxic effects on the
subject.
Taulli R, Bersani F, Foglizzo V, Linari A, Vigna E, Ladanyi M, Tuschl T, and Ponzetto C,
"The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in
xenotransplanted mice by promoting myogenic differentiation",
J. Clin. Investigation. 119: (8), 2366



References:

1. Katoh M, Shaw C,  Xu Q, Van Driessche N ,Morio T , Kuwayama H, Obara S, Urushihara H, Tanaka Y, and Gad Shaulsky J,
"An orderly retreat: De-differentiation is a regulated process".
Proc. Natl. Acad. Sci. USA, vol. 101, no. 18, pp. 7005-7010 (May 4, 2004).

2. Frenster JH, and Hovsepian JA,  ( 2010 )
      "Analysis of Intra-Nuclear Entropy Changes during EMT Activation".



PubMed search for "avalanche" on August 1, 2010:

Results: 1 to 20 of 1197

1.
Akiba M, Tsujino K, Sasaki M.
Opt Lett. 2010 Aug 1;35(15):2621-3. doi: 10.1364/OL.35.002621.PMID: 20680078 [PubMed - in process]Related citations
2.
Magee D, Tanner SF, Waller M, Tan AL, McGonagle D, Jeavons AP.
Phys Med Biol. 2010 Aug 21;55(16):4755-69. Epub 2010 Jul 30.PMID: 20671357 [PubMed - in process]Related citations
3.
Sagaert X, Tousseyn T.
Discov Med. 2010 Jul;10(50):79-86.PMID: 20670602 [PubMed - in process]Related citations
4.
Boss A, Bisdas S, Kolb A, Hofmann M, Ernemann U, Claussen CD, Pfannenberg C, Pichler BJ, Reimold M, Stegger L.
J Nucl Med. 2010 Aug;51(8):1198-205. Epub 2010 Jul 21.PMID: 20660388 [PubMed - in process]Related citations
5.
Chiesa C, Pacifico L, Anania C, Poggiogalle E, Chiarelli F, Osborn JF.
Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):405-16.PMID: 20646336 [PubMed - in process]Related citations
6.
Shen HB, Chou KC.
J Biomol Struct Dyn. 2010 Oct;28(2):175-86.PMID: 20645651 [PubMed - in process]Related citations
7.
Hahn G, Petermann T, Havenith MN, Yu S, Singer W, Plenz D, Nikolic D.
J Neurophysiol. 2010 Jul 14. [Epub ahead of print]PMID: 20631221 [PubMed - as supplied by publisher]Related citations
8.
Paal P, Braun P, Brugger H, Strappazzon G, Falk M.
BMJ. 2010 Jul 14;341:c3778. doi: 10.1136/bmj.c3778. No abstract available. PMID: 20630957 [PubMed - indexed for MEDLINE]Related citations
9.
Benayoun M, Cowan JD, van Drongelen W, Wallace E.
PLoS Comput Biol. 2010 Jul 8;6(7):e1000846.PMID: 20628615 [PubMed - in process]Free PMC ArticleFree textRelated citations
10.
Hunter WC, Miyaoka RS, Macdonald LR, Lewellen TK.
IEEE Nucl Sci Symp Conf Rec (1997). 2009 Oct 24;2009:2662-2665.PMID: 20625461 [PubMed]Related citations
11.
Leisner M, Carstensen J, Föll H.
Nanoscale Res Lett. 2010 May 14;5(7):1190-1194.PMID: 20596354 [PubMed]Free PMC ArticleFree textRelated citations
12.
Bogle LB, Boyd JJ, McLaughlin KA.
Wilderness Environ Med. 2010 Mar;21(1):28-34. Epub 2009 Dec 22.PMID: 20591351 [PubMed - in process]Related citations
13.
Li K, Liu HD, Zhou Q, McIntosh D, Campbell JC.
Opt Express. 2010 May 24;18(11):11713-9. doi: 10.1364/OE.18.011713.PMID: 20589031 [PubMed - in process]Related citations
14.
Pomarico E, Sanguinetti B, Thew R, Zbinden H.
Opt Express. 2010 May 10;18(10):10750-9. doi: 10.1364/OE.18.010750.PMID: 20588927 [PubMed - in process]Related citations
15.
Li DU, Arlt J, Richardson J, Walker R, Buts A, Stoppa D, Charbon E, Henderson R.
Opt Express. 2010 May 10;18(10):10257-69. doi: 10.1364/OE.18.010257.PMID: 20588879 [PubMed - in process]Related citations
16.
Malinauskas M, Zukauskas A, Bickauskaite G, Gadonas R, Juodkazis S.
Opt Express. 2010 May 10;18(10):10209-21. doi: 10.1364/OE.18.010209.PMID: 20588875 [PubMed - in process]Related citations
17.
van Schaik W, Willems RJ.
Clin Microbiol Infect. 2010 Jun;16(6):527-32.PMID: 20569263 [PubMed - in process]Related citations
18.
Akutagawa E, Konishi M.
J Comp Neurol. 2010 Aug 1;518(15):3086-100.PMID: 20533361 [PubMed - in process]Related citations
19.
Huang T, Shi XH, Wang P, He Z, Feng KY, Hu L, Kong X, Li YX, Cai YD, Chou KC.
PLoS One. 2010 Jun 4;5(6):e10972.PMID: 20532046 [PubMed - in process]Free PMC ArticleFree textRelated citations
20.
Treumer F, Sattler B, Bunse A, Klettner A, Hillenkamp J, Roider J.
Br J Ophthalmol. 2010 May 28. [Epub ahead of print]PMID: 20511338 [PubMed - as supplied by publisher]Related citations

Conclusions from Embryoma Genomics:

1. Each cell retains all of its embryonic genes for a lifetime.

2. Controls for embryonic genes are often absent in adults.

3. Uncontrolled embryonic genes can replicate wildly.

4.  Replicating genes participate in  intra-cellular competition.

5.  The basis for gene competition is selective transcription.

6.  MicroRNAs can reprogram embryomic transcription.

7.  Gene reprogramming can produce normal phenotypes.

8.  Normal phenotypes can by-pass chromosomal lesions.

9.  MicroRNA therapy may need to be permanent.

10. Transplantation of microRNAs could be preferred.

http://www.embryomas.net/




Conclusions from Euchromatin Thermodynamic Pathways.

1. Pathways within cell genomes involve a flow of information.

2. Information can flow by direct contact or by third parties.

3. Direct contact within whole genomes is difficult to regulate.

4. DNA-DNA direct contects are influenced by agents.

5. Nuclear agents include hydrophilic ionic and hydrophobic conforming ligands.

6. Third parties within genomes involve RNAs and proteins.

7.  RNAs and proteins are easy to regulate or reverse.

8.  Information can be shared, lost, or transformed.

9. System information can be hidden during system isolation.

10.  Local information can be permanently lost during system entropy.

http://www.embryomas.net/




Further Topics in:  Euchromatin,  active DNA, and  RNA  ribo-regulators:

Links to Current Research in Euchromatin:
Links to Euchromatin Activator RNA Reviews:
Links to Euchromatin Activator RNA Research:
Links to Ultrastructural Probes of DNase I-Sensitive Sites:
Links to RNA as a Therapeutic Agent:
Links to Hodgkin Lymphoma Immuno-Pathology:
Links to Activated T-Lymphocyte Immunotherapy:
Links to Medical Systems Biology:
Links to Selective Gene Transcription:
Links to RNA-Induced Epigenetics:
Links to RNA-Induced Embryogenesis:
Links to RNA and Biological Causality:
Links to Reprogramming and Neoplasia:

A Brief History of Activator RNA:

"Ultrastructural Probes of Active DNA Sites, and the RNA Activators of DNA".
(PowerPoint Presentation).


Top of Page - Euchromatin NetworkEuchromatin ResearchResearch in Quantitative Radiology


For Further Information and Feedback:

Jeannette A. Hovsepian, M.D.
E-mail: frensasc@ix.netcom.com
Phone:  +1 650 367 6483



euchromatin: "the most active portion of the genome within the cell nucleus".
embryoma:  "adult neoplasm expressing one or more embryo-exclusive genes".
entropy:  "maximum entropy defines the isolated reaction steady-state equilibrium".